Dynamics of the antiviral activity of N-methanocarbathymidine against herpes simplex virus type 1 in cell culture

This publication has 22 references indexed in Scilit:

• Potent In Vivo Antiviral Activity of the Herpes Simplex Virus Primase-Helicase Inhibitor BAY 57-1293
  Antimicrobial Agents and Chemotherapy, 2002
• New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease
  Nature Medicine, 2002
• Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease
  Nature Medicine, 2002
• Metabolic pathways of N-methanocarbathymidine, a novel antiviral agent, in native and herpes simplex virus type 1 infected Vero cells
  Antiviral Research, 2002
• Kinetics and Crystal Structure of the Wild-Type and the Engineered Y101F Mutant of Herpes simplex Virus Type 1 Thymidine Kinase Interacting with (North)-methanocarba-thymidine^,
  Biochemistry, 2000
• A comparison of the antiviral agents 2′-nor-2′-deoxyguanosine and acyclovir: Uptake and phosphorylation in tissue culture and kinetics of in vitro inhibition of viral and cellular DNA polymerases by their respective triphosphates
  Biochemical and Biophysical Research Communications, 1983
• 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.
  Proceedings of the National Academy of Sciences, 1983
• Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine
  Antimicrobial Agents and Chemotherapy, 1983
• Comparative Efficacy of Antiherpes Drugs against Different Strains of Herpes Simplex Virus
  The Journal of Infectious Diseases, 1980
• Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine
  Proceedings of the National Academy of Sciences, 1977